Dasiglucagon Works for Kids; New Diabetes Dietary Guidelines; Post-COVID Thyroiditis
(MedPage Today) -- Dasiglucagon reduced the need for IV glucose by 55% versus placebo in a pediatric population with congenital hyperinsulinism, according to a second phase III clinical trial by Zealand Pharma.
The American Diabetes Association...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Children | Clinical Trials | Diabetes | Diets | Endocrinology | New Zealand Health | Nutrition | Pediatrics | Pharmaceuticals | Thyroiditis